Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Treating cofactors can reverse the expansion of a primary disease epidemic

Authors: Lee R Gibson, Bingtuan Li, Susanna K Remold

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Cofactors, "nuisance" conditions or pathogens that affect the spread of a primary disease, are likely to be the norm rather than the exception in disease dynamics. Here we present a "simplest possible" demographic model that incorporates two distinct effects of cofactors: that on the transmission of the primary disease from an infected host bearing the cofactor, and that on the acquisition of the primary disease by an individual that is not infected with the primary disease but carries the cofactor.

Methods

We constructed and analyzed a four-patch compartment model that accommodates a cofactor. We applied the model to HIV spread in the presence of the causal agent of genital schistosomiasis, Schistosoma hematobium, a pathogen commonly co-occurring with HIV in sub-Saharan Africa.

Results

We found that cofactors can have a range of effects on primary disease dynamics, including shifting the primary disease from non-endemic to endemic, increasing the prevalence of the primary disease, and reversing demographic growth when the host population bears only the primary disease to demographic decline. We show that under parameter values based on the biology of the HIV/S. haematobium system, reduction of the schistosome-bearing subpopulations (e.g. through periodic use of antihelminths) can slow and even reverse the spread of HIV through the host population.

Conclusions

Typical single-disease models provide estimates of future conditions and guidance for direct intervention efforts relating only to the modeled primary disease. Our results suggest that, in circumstances under which a cofactor affects the disease dynamics, the most effective intervention effort might not be one focused on direct treatment of the primary disease alone. The cofactor model presented here can be used to estimate the impact of the cofactor in a particular disease/cofactor system without requiring the development of a more complicated model which incorporates many other specific aspects of the chosen disease/cofactor pair. Simulation results for the HIV/S. haematobium system have profound implications for disease management in developing areas, in that they provide evidence that in some cases treating cofactors may be the most successful and cost-effective way to slow the spread of primary diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bongaarts J, Buettner T, Heilig G, Pelletier F: Has the HIV epidemic peaked?. Population and Development Review. 2008, 34: 199-244. 10.1111/j.1728-4457.2008.00217.x.CrossRef Bongaarts J, Buettner T, Heilig G, Pelletier F: Has the HIV epidemic peaked?. Population and Development Review. 2008, 34: 199-244. 10.1111/j.1728-4457.2008.00217.x.CrossRef
2.
go back to reference Friis H, Michaelsen KF: Micronutrients and HIV infection: a review. Eur J Clin Nutr. 1998, 52: 157-163. 10.1038/sj.ejcn.1600546.CrossRefPubMed Friis H, Michaelsen KF: Micronutrients and HIV infection: a review. Eur J Clin Nutr. 1998, 52: 157-163. 10.1038/sj.ejcn.1600546.CrossRefPubMed
3.
go back to reference Timbo BB, Tollefson L: Nutrition: a cofactor in HIV disease. J Am Diet Assoc. 1994, 94: 1018-1022. 10.1016/0002-8223(94)92196-2.CrossRefPubMed Timbo BB, Tollefson L: Nutrition: a cofactor in HIV disease. J Am Diet Assoc. 1994, 94: 1018-1022. 10.1016/0002-8223(94)92196-2.CrossRefPubMed
4.
go back to reference Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J: Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995, 11: 1049-1061. 10.1089/aid.1995.11.1049.CrossRefPubMed Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J: Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995, 11: 1049-1061. 10.1089/aid.1995.11.1049.CrossRefPubMed
5.
go back to reference Mehta S, Fawzi W: Effects of vitamins, including vitamin A, on HIV/AIDS prevention. Vitamin A. Edited by: Litwack G. 2007, San Diego: Elsevier Academic Press INC, 75: 355-383. full_text.CrossRef Mehta S, Fawzi W: Effects of vitamins, including vitamin A, on HIV/AIDS prevention. Vitamin A. Edited by: Litwack G. 2007, San Diego: Elsevier Academic Press INC, 75: 355-383. full_text.CrossRef
6.
go back to reference Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996, 382: 722-725. 10.1038/382722a0.CrossRefPubMed Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996, 382: 722-725. 10.1038/382722a0.CrossRefPubMed
7.
go back to reference Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IMJ, Self SG, Corey L: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One. 2008, 3: e2230-10.1371/journal.pone.0002230.CrossRefPubMedPubMedCentral Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IMJ, Self SG, Corey L: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One. 2008, 3: e2230-10.1371/journal.pone.0002230.CrossRefPubMedPubMedCentral
8.
go back to reference Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004, 35: 435-445. 10.1097/00126334-200404150-00001.CrossRefPubMed Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004, 35: 435-445. 10.1097/00126334-200404150-00001.CrossRefPubMed
9.
go back to reference Stillwaggon E: AIDS and the ecology of poverty. 2006, New York: Oxford University Press Stillwaggon E: AIDS and the ecology of poverty. 2006, New York: Oxford University Press
10.
go back to reference Lietman TBS, Porco T: Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am J Public Health. 1997, 87: 1923-1927. 10.2105/AJPH.87.12.1923.CrossRefPubMedPubMedCentral Lietman TBS, Porco T: Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am J Public Health. 1997, 87: 1923-1927. 10.2105/AJPH.87.12.1923.CrossRefPubMedPubMedCentral
11.
go back to reference Lello J, Boag B, Fenton A, Stevenson IR, Hudson PJ: Competition and mutualism among the gut helminths of a mammalian host. Nature. 2004, 428: 840-844. 10.1038/nature02490.CrossRefPubMed Lello J, Boag B, Fenton A, Stevenson IR, Hudson PJ: Competition and mutualism among the gut helminths of a mammalian host. Nature. 2004, 428: 840-844. 10.1038/nature02490.CrossRefPubMed
12.
go back to reference Jolles AE, Ezenwa VO, Etienne RS, Turner WC, Olff H: Interactions between macroparasites and microparasites drive infection patterns in free-ranging African buffalo. Ecology. 2008, 89: 2239-2250. 10.1890/07-0995.1.CrossRefPubMed Jolles AE, Ezenwa VO, Etienne RS, Turner WC, Olff H: Interactions between macroparasites and microparasites drive infection patterns in free-ranging African buffalo. Ecology. 2008, 89: 2239-2250. 10.1890/07-0995.1.CrossRefPubMed
13.
go back to reference Petney TN, Andrews RH: Multiparasite communities in animals and humans-frequency, structure and pathogenic signficance. Int J Parasitol. 1998, 28: 377-393. 10.1016/S0020-7519(97)00189-6.CrossRefPubMed Petney TN, Andrews RH: Multiparasite communities in animals and humans-frequency, structure and pathogenic signficance. Int J Parasitol. 1998, 28: 377-393. 10.1016/S0020-7519(97)00189-6.CrossRefPubMed
14.
go back to reference Alto BW, Lounibos LP, Mores CN, Reiskind MH: Larval competition alters susceptibility of adult Aedes mosquitoes to dengue infection. Proc Biol Sci. 2008, 275: 463-471. 10.1098/rspb.2007.1497.CrossRefPubMed Alto BW, Lounibos LP, Mores CN, Reiskind MH: Larval competition alters susceptibility of adult Aedes mosquitoes to dengue infection. Proc Biol Sci. 2008, 275: 463-471. 10.1098/rspb.2007.1497.CrossRefPubMed
15.
go back to reference Seabloom EW, Hosseini PR, Power AG, Borer ET: Diversity and composition of viral communities: coinfection of barley and cereal yellow dwarf viruses in californial grasslands. Am Nat. 2009, 173: E79-E98. 10.1086/596529.CrossRefPubMed Seabloom EW, Hosseini PR, Power AG, Borer ET: Diversity and composition of viral communities: coinfection of barley and cereal yellow dwarf viruses in californial grasslands. Am Nat. 2009, 173: E79-E98. 10.1086/596529.CrossRefPubMed
16.
go back to reference Abu-Raddad LJ, Patnaik P, Kublin JG: Dual infection with HIV and Malaria fuels the spread of both diseases in Sub-Saharan Africa. Science. 2006, 314: 1603-1606. 10.1126/science.1132338.CrossRefPubMed Abu-Raddad LJ, Patnaik P, Kublin JG: Dual infection with HIV and Malaria fuels the spread of both diseases in Sub-Saharan Africa. Science. 2006, 314: 1603-1606. 10.1126/science.1132338.CrossRefPubMed
17.
go back to reference Santos ML, Ponce MA, Vendramini SH, Villa TC, Santos NS, Wysocki AD, Kuyumijian FG, Gazetta CE: The epidemiological dimension of TB/HIV co-infection. Rev Lat Am Enfermagem. 2009, 17: 683-688.CrossRefPubMed Santos ML, Ponce MA, Vendramini SH, Villa TC, Santos NS, Wysocki AD, Kuyumijian FG, Gazetta CE: The epidemiological dimension of TB/HIV co-infection. Rev Lat Am Enfermagem. 2009, 17: 683-688.CrossRefPubMed
18.
go back to reference Anderson RM, May RM, McLean AR: Possible demographic consequences of AIDS in developing countries. Nature. 1988, 332: 228-234. 10.1038/332228a0.CrossRefPubMed Anderson RM, May RM, McLean AR: Possible demographic consequences of AIDS in developing countries. Nature. 1988, 332: 228-234. 10.1038/332228a0.CrossRefPubMed
19.
go back to reference Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT: The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature. 1991, 352: 581-589. 10.1038/352581a0.CrossRefPubMed Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT: The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature. 1991, 352: 581-589. 10.1038/352581a0.CrossRefPubMed
20.
go back to reference Garnett GP, Anderson RM: Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 9: 500-513.CrossRefPubMed Garnett GP, Anderson RM: Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 9: 500-513.CrossRefPubMed
21.
go back to reference Bautista CT, Sateren WB, Sanchez JL, Rathore Z, Singer DE, Birx DL, Scott PT: HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003). J Acquir Immune Defic Syndr. 2006, 43: 351-355. 10.1097/01.qai.0000243051.35204.d0.CrossRefPubMed Bautista CT, Sateren WB, Sanchez JL, Rathore Z, Singer DE, Birx DL, Scott PT: HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003). J Acquir Immune Defic Syndr. 2006, 43: 351-355. 10.1097/01.qai.0000243051.35204.d0.CrossRefPubMed
22.
go back to reference Davis SF, Rosen DH, Steinberg S, Wortley PM, Karon JM, Gwinn M: Trends in HIV prevalence among childbearing women in the United States, 1989-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 158-164.CrossRefPubMed Davis SF, Rosen DH, Steinberg S, Wortley PM, Karon JM, Gwinn M: Trends in HIV prevalence among childbearing women in the United States, 1989-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 158-164.CrossRefPubMed
23.
go back to reference Emejulu AC, Alabaronye FF, Ezenwaji HM, Okafor FC: Investigation into the prevalence of urinary schistosomiasis in the Agulu Lake area of Anambra State, Nigeria. J Helminthol. 1994, 68: 119-123. 10.1017/S0022149X00013638.CrossRefPubMed Emejulu AC, Alabaronye FF, Ezenwaji HM, Okafor FC: Investigation into the prevalence of urinary schistosomiasis in the Agulu Lake area of Anambra State, Nigeria. J Helminthol. 1994, 68: 119-123. 10.1017/S0022149X00013638.CrossRefPubMed
24.
go back to reference Ugbomoiko US: The prevalence, incidence and distribution of human urinary schistosomiasis in Edo State, Nigeria. Aust N Z J Public Health. 2000, 24: 642-643. 10.1111/j.1467-842X.2000.tb00537.x.CrossRefPubMed Ugbomoiko US: The prevalence, incidence and distribution of human urinary schistosomiasis in Edo State, Nigeria. Aust N Z J Public Health. 2000, 24: 642-643. 10.1111/j.1467-842X.2000.tb00537.x.CrossRefPubMed
25.
go back to reference Castillo-Chavez C, Brauer F: Mathematical Models in Population Biology and Epidemiology. 2001, New York: Springer-Verlag Castillo-Chavez C, Brauer F: Mathematical Models in Population Biology and Epidemiology. 2001, New York: Springer-Verlag
26.
go back to reference Busenberg S, van den Driessch P: Analysis of a disease transmission model in a population with varying size. J Math Biol. 1990, 28: 257-270. 10.1007/BF00178776.CrossRefPubMed Busenberg S, van den Driessch P: Analysis of a disease transmission model in a population with varying size. J Math Biol. 1990, 28: 257-270. 10.1007/BF00178776.CrossRefPubMed
27.
go back to reference Hofbauer J, Sigmund K: Evolutionary Games and Population Dynamics. 1998, Cambridge: Cambridge University PressCrossRef Hofbauer J, Sigmund K: Evolutionary Games and Population Dynamics. 1998, Cambridge: Cambridge University PressCrossRef
28.
go back to reference Thieme HR: Mathematics in Population Biology. 2003, Princeton and Oxford: Princeton University Press Thieme HR: Mathematics in Population Biology. 2003, Princeton and Oxford: Princeton University Press
30.
go back to reference Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, Tanner M: Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg. 2003, 69: 420-428.PubMed Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, Tanner M: Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg. 2003, 69: 420-428.PubMed
31.
go back to reference Poggensee G, Feldmeier H: Female genital schistosomiasis: facts and hypotheses. Acta Trop. 2001, 79: 193-210. 10.1016/S0001-706X(01)00086-9.CrossRefPubMed Poggensee G, Feldmeier H: Female genital schistosomiasis: facts and hypotheses. Acta Trop. 2001, 79: 193-210. 10.1016/S0001-706X(01)00086-9.CrossRefPubMed
32.
go back to reference Poggensee G, Kiwelu I, Weger V, GÖppner D, Diedrich T, Krantz I, Feldmeier H: Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis. 2000, 181: 1210-1213. 10.1086/315345.CrossRefPubMed Poggensee G, Kiwelu I, Weger V, GÖppner D, Diedrich T, Krantz I, Feldmeier H: Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis. 2000, 181: 1210-1213. 10.1086/315345.CrossRefPubMed
33.
go back to reference N'Goran EK, Utzinger J, Gnaka HN, Yapi A, N'Guessan NA, Kigbafori S, Lengeler C, Chollet J, Shuhua X, Tanner M: Randomized, double-blind, placebo controlled trial of oral Arthmether for the prevention of patent Schistosoma Haematobium infections. Am J Trop Med Hyg. 2003, 68: 24-32.PubMed N'Goran EK, Utzinger J, Gnaka HN, Yapi A, N'Guessan NA, Kigbafori S, Lengeler C, Chollet J, Shuhua X, Tanner M: Randomized, double-blind, placebo controlled trial of oral Arthmether for the prevention of patent Schistosoma Haematobium infections. Am J Trop Med Hyg. 2003, 68: 24-32.PubMed
34.
go back to reference Diekmann O, Heesterbeek BA, Metz JA: On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol. 1990, 28: 365-382. 10.1007/BF00178324.CrossRefPubMed Diekmann O, Heesterbeek BA, Metz JA: On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol. 1990, 28: 365-382. 10.1007/BF00178324.CrossRefPubMed
35.
go back to reference Lloyd-Smith JO, Poss M, Grengell BT: HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology. 2008, 135: 795-806. 10.1017/S0031182008000292.CrossRefPubMed Lloyd-Smith JO, Poss M, Grengell BT: HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology. 2008, 135: 795-806. 10.1017/S0031182008000292.CrossRefPubMed
Metadata
Title
Treating cofactors can reverse the expansion of a primary disease epidemic
Authors
Lee R Gibson
Bingtuan Li
Susanna K Remold
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-248

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine